MedPath

PREEMIE: Study for Treatment of PDA in Premature Infants

Not Applicable
Recruiting
Conditions
Patent Ductus Arteriosus (PDA)
Interventions
Device: Bloom Micro Occluder System
Registration Number
NCT06587282
Lead Sponsor
Merit Medical Systems, Inc.
Brief Summary

This multicenter, single arm, prospective, non-randomized study is designed to evaluate the safety and effectiveness of The Bloom Micro Occluder System for the treatment of patent ductus arteriosus (PDA) in pre-mature infants over a period of 6 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
55
Inclusion Criteria
  • Subject is age ≥5 days at time of enrollment.
  • Subject has a diagnosis of a hemodynamically significant patent ductus arteriosus (PDA) requiring closure.
  • Subject has a PDA is ≤4.0 mm in diameter.
  • Subject has a PDA is ≥5 mm in length.
  • Subject's weight is between 600-2500 grams at time of enrollment.
Exclusion Criteria
  • Subject has pre-existing coarctation of the aorta.
  • Subject has pre-existing left pulmonary artery stenosis.
  • Subject has an Intracardiac thrombus that may interfere with the implant procedure
  • Subject has other known hemodynamically significant congenital heart disease conditions at time of enrollment requiring intervention, e.g., valvular atresia, Tetralogy of Fallot, atrial septal defect, ventricular septal defect, transposition of the great vessels, etc.
  • Subject has an active systemic infection at the time of enrollment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
PDA treatmentBloom Micro Occluder SystemPDA treated with Bloom Micro Occluder System
Primary Outcome Measures
NameTimeMethod
Safety Endpoint30 days

Composite rate of device-related Major Adverse Events (MAE) of interest through 30 days following the index procedure.

Effectiveness Endpoint6 Months

The rate of Clinical Success achieved at the 6-month follow-up visit.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (9)

UC Davis Health

🇺🇸

Sacramento, California, United States

UC San Diego-Rady Children's Hospital

🇺🇸

San Diego, California, United States

Memorial Healthcare System-Joe DiMaggio Children's Hospital

🇺🇸

Hollywood, Florida, United States

Children's Healthcare of Atlanta

🇺🇸

Atlanta, Georgia, United States

Washington University-St. Louis Children's Hospital

🇺🇸

Saint Louis, Missouri, United States

Nationwide Children's Hospital

🇺🇸

Columbus, Ohio, United States

Le Bonheur Children's Hospital

🇺🇸

Memphis, Tennessee, United States

UT Southwestern Medical Center

🇺🇸

Dallas, Texas, United States

Herma Heart Institute-Children's Wisconsin

🇺🇸

Milwaukee, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath